Certara, Inc.
NASDAQ:CERT
11.96 (USD) • At close January 15, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Certara, Inc. |
Symbool | CERT |
Munteenheid | USD |
Prijs | 11.96 |
Beurswaarde | 1,925,416,480 |
Dividendpercentage | 0% |
52-weken bereik | 9.41 - 19.87 |
Industrie | Health Information Services |
Sector | Healthcare |
CEO | Dr. William F. Feehery Ph.D. |
Website | https://www.certara.com |
An error occurred while fetching data.
Over Certara, Inc.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)